Sommaire

• • ·Table of Contents

    Page :A5

    
• • ·Editorial Board

    Page :A10

    
• • ·Information for Authors

    Page :A11

    

• Editorials

  • ·Antiplatelet agents make a comeback in ST-elevation myocardial infarction

    Page :603-606

    Stephen D. Wiviott, James A. de Lemos

    Plan Plan
  • ·Population attributable fraction: Its implications for genetic epidemiology and illness prevention

    Page :607-609

    Igor Karp, Eric Topol, Louise Pilote

    
  • ·Genetic association studies; The good, the bad, and the ugly

    Page :610-612

    Mark P. Donahue, William E. Kraus

    Plan Plan
  • ·Benefits of coronary revascularization: A failure to communicate

    Page :613-614

    Lawrence Liao

    
  • ·Pressure and flow across severe stenoses: Does the intra-aortic balloon pump do its job?

    Page :615-616

    Morton J. Kern

    

• Curriculum in Cardiology

  • ·Statin therapy in heart failure: Prognostic effects and potential mechanisms

    Page :617-623

    Jeffrey G. Shanes, Kira N. Minadeo, Ann Moret, Mordechai Groner, Sean A. Tabaie

    Résumé Résumé Plan Plan  

• Trial Design

  • ·Rationale and design of a randomized clinical trial of ?-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome

    Page :624-631

    Ronald V. Lacro, Harry C. Dietz, Lisa M. Wruck, Timothy J. Bradley, Steven D. Colan, Richard B. Devereux, Gloria L. Klein, Jennifer S. Li, L. LuAnn Minich, Stephen M. Paridon, Gail D. Pearson, Beth F. Printz, Reed E. Pyeritz, Elizabeth Radojewski, Mary J. Roman, J. Philip Saul, Mario P. Stylianou, Lynn Mahony, for the Pediatric Heart Network Investigators

    Résumé Résumé Plan Plan  
  • ·Rationale and design of the fractional flow reserve versus angiography for multivessel evaluation (FAME) study

    Page :632-636

    William F. Fearon, Pim A.L. Tonino, Bernard De Bruyne, Uwe Siebert, Nico H.J. Pijls, for the FAME Study Investigators

    Résumé Résumé Plan Plan  

• Clinical Investigations

  • ·Effects of carvedilol early after myocardial infarction: Analysis of the first 30 days in Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN)

    Page :637-644

    Gregg C. Fonarow, Mary Ann Lukas, Michele Robertson, Wilson S. Colucci, Henry J. Dargie

    Résumé Résumé Plan Plan  
  • ·Vitamin C restores the contractile response to dobutamine and improves myocardial efficiency in patients with heart failure after anterior myocardial infarction

    Page :645.e1

    Toshiro Shinke, Junya Shite, Hideyuki Takaoka, Katsuya Hata, Nobutaka Inoue, Ryohei Yoshikawa, Hidenari Matsumoto, Hiroyuki Masai, Satoshi Watanabe, Tohru Ozawa, Hiromasa Otake, Daisuke Matsumoto, Ken-ichi Hirata, Mitsuhiro Yokoyama

    Résumé Résumé Plan Plan  
  • ·Effects of ?-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome

    Page :645.e9

    Alberto Palazzuoli, Donald S. Silverberg, Francesca Iovine, Anna Calabrò, Maria S. Campagna, Maddalena Gallotta, Ranuccio Nuti

    Résumé Résumé Plan Plan  
  • ·Correction

    Page :646

    
  • ·Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: A report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)

    Page :647-654

    Barry H. Greenberg, William T. Abraham, Nancy M. Albert, Karen Chiswell, Robert Clare, Wendy Gattis Stough, Mihai Gheorghiade, Christopher M. O'Connor, Jie Lena Sun, Clyde W. Yancy, James B. Young, Gregg C. Fonarow

    
  • ·Distribution of creatine kinase in the general population: Implications for statin therapy

    Page :655-661

    Lizzy M. Brewster, Gideon Mairuhu, August Sturk, Gert A. van Montfrans

    Résumé Résumé Plan Plan  
  • ·Understanding of the benefits of coronary revascularization procedures among patients who are offered such procedures

    Page :662-668

    Jeff Whittle, Joseph Conigliaro, Chester B. Good, Mary E. Kelley, Melissa Skanderson

    Résumé Résumé Plan Plan
  • ·Comparison of angiographically guided direct stenting technique with direct stenting and optimal balloon angioplasty guided with intravascular ultrasound. The multicenter, randomized trial results

    Page :669-675

    Robert J. Gil, Tomasz Paw?owski, Dariusz Dudek, Grzegorz Horszczaruk, Krzysztof Z?mudka, Maciej Lesiak, Adam Witkowski, Andrzej Ocha?a, Jacek Kubica, on behalf of Investigators of Direct Stenting vs Optimal Angioplasty Trial (DIPOL)

    Résumé Résumé Plan Plan  
  • ·The impact of oral antiplatelet responsiveness on the long-term prognosis after coronary stenting

    Page :676-681

    Stefanos G. Foussas, Michael N. Zairis, Nikolaos G. Patsourakos, Stamatis S. Makrygiannis, Evdokia N. Adamopoulou, Stylianos M. Handanis, Athanasios A. Prekates, Constantine N. Fakiolas, Evangelos G. Pissimissis, Christopher D. Olympios, Spyros K. Argyrakis

    Résumé Résumé Plan Plan  
  • ·Outcome in the elderly undergoing percutaneous coronary intervention with sirolimus-eluting stents: Results from the prospective multicenter German Cypher Stent Registry

    Page :682-687

    Marcus Wiemer, Christoph Langer, Tanja Kottmann, Dieter Horstkotte, Christian Hamm, Thomas H. Pfannebecker, Ulrich Tebbe, Steffen Schneider, Jochen Senges

    Résumé Résumé Plan Plan  
  • ·Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era

    Page :688-693

    Raisuke Iijima, Gjin Ndrepepa, Julinda Mehilli, Christina Markwardt, Olga Bruskina, Jürgen Pache, Maryam Ibrahim, Albert Schömig, Adnan Kastrati

    Résumé Résumé Plan Plan  
  • ·Effect of caffeine on platelet inhibition by clopidogrel in healthy subjects and patients with coronary artery disease

    Page :694.e1

    Eli I. Lev, Mehmet E. Arikan, Muthiah Vaduganathan, Carlos L. Alviar, Armando Tellez, Nilesh Mathuria, Angela Builes, Juan F. Granada, Ian del Conde, Neal S. Kleiman

    Résumé Résumé Plan Plan  
  • ·Impact of bivalirudin on outcomes after percutaneous coronary revascularization with drug-eluting stents

    Page :695-701

    Dmitriy N. Feldman, S. Chiu Wong, Christopher L. Gade, David S. Gidseg, Geoffrey Bergman, Robert M. Minutello

    Résumé Résumé Plan Plan  
  • ·Preliminary experience with intravenous P2Y₁₂ platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction: Results of the Safety, Tolerability and Effect on Patency in Acute Myocardial Infarction (STEP-AMI) angiographic trial

    Page :702-709

    Adam B. Greenbaum, E. Magnus Ohman, C. Michael Gibson, Steven Borzak, Amanda L. Stebbins, Mei Lu, Michel R. Le May, Jill E. Stankowski, Hakan Emanuelsson, W. Douglas Weaver

    Résumé Résumé Plan Plan  
  • ·Exercise capacity and quality of life after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: Results from the Autologous Stem cell Transplantation in Acute Myocardial Infarction (ASTAMI) randomized controlled trial

    Page :710.e1

    Ketil Lunde, Svein Solheim, Svend Aakhus, Harald Arnesen, Torbjørn Moum, Michael Abdelnoor, Torstein Egeland, Knut Endresen, Arnfinn Ilebekk, Arild Mangschau, Kolbjørn Forfang

    Résumé Résumé Plan Plan  
  • ·Predictors of weight change in overweight patients with myocardial infarction

    Page :711-717

    Yazid Y. Fadl, Harlan M. Krumholz, Mikhail Kosiborod, Frederick A. Masoudi, Pamela N. Peterson, Kimberly J. Reid, William S. Weintraub, Donna M. Buchanan, John A. Spertus

    Résumé Résumé Plan Plan  
  • ·PPAR? gene C161T substitution is associated with reduced risk of coronary artery disease and decreased proinflammatory cytokine expression

    Page :718-724

    Yu Liu, Zuyi Yuan, Yan Liu, Jijun Zhang, Ping Yin, Dongqi Wang, Yanni Wang, Chiharu Kishimoto, Aiqun Ma

    Résumé Résumé Plan Plan  
  • ·A 6-month randomized pilot study of black tea and cardiovascular risk factors

    Page :724.e1

    Kenneth J. Mukamal, Kristen MacDermott, Joe A. Vinson, Noriko Oyama, Warren J. Manning, Murray A. Mittleman

    Résumé Résumé Plan Plan  
  • ·Effects of intra-aortic balloon counterpulsation on coronary pressure in patients with stenotic coronary arteries

    Page :725-731

    Hidetoshi Yoshitani, Takashi Akasaka, Shuichiro Kaji, Takahiro Kawamoto, Teruyoshi Kume, Yoji Neishi, Yuji Koyama, Kiyoshi Yoshida

    Résumé Résumé Plan Plan  
  • ·Dual antiplatelet agent failure: A new syndrome or clinical nonentity?

    Page :732-735

    Geoffrey D. Barnes, Jin Li, Eva Kline-Rogers, Ameeth Vedre, David F. Armstrong, James B. Froehlich, Kim A. Eagle, Hitinder S. Gurm

    Résumé Résumé Plan Plan  
  • ·C-terminal pro–endothelin-1 offers additional prognostic information in patients after acute myocardial infarction : Leicester Acute Myocardial Infarction Peptide (LAMP) Study

    Page :736-742

    Sohail Q. Khan, Onkar Dhillon, Joachim Struck, Paulene Quinn, Nils G. Morgenthaler, Ian B. Squire, Joan E. Davies, Andreas Bergmann, Leong L. Ng

    Résumé Résumé Plan Plan  
  • ·Infarct size, ejection fraction, and mortality in diabetic patients with acute myocardial infarction treated with thrombolytic therapy

    Page :743-750

    Jorge R. Alegria, Todd D. Miller, Raymond J. Gibbons, Qi-Long Yi, Salim Yusuf, for the Collabhorative Organization of RheothRx Evaluation (CORE) Trial Investigators

    Résumé Résumé Plan Plan  
  • ·Low plasma levels of adiponectin are associated with low risk for future cardiovascular events in patients with clinical evident vascular disease

    Page :750.e1

    Gideon R. Hajer, Yolanda van der Graaf, Jobien K. Olijhoek, Michael Edlinger, Frank L.J. Visseren

    Résumé Résumé Plan Plan
  • ·Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease

    Page :751-758

    Benjamin D. Horne, Nicola J. Camp, John F. Carlquist, Joseph B. Muhlestein, Matthew J. Kolek, Zachary P. Nicholas, Jeffrey L. Anderson

    Résumé Résumé Plan Plan  
  • ·Association of ?-adrenoceptor polymorphisms with cardiac autonomic modulation in Japanese males

    Page :759-766

    Tetsuro Matsunaga, Koichiro Yasuda, Tetsuya Adachi, Ning Gu, Tsubasa Yamamura, Toshio Moritani, Gozoh Tsujimoto, Kinsuke Tsuda

    Résumé Résumé Plan Plan  
  • ·Cardiac Certificate of Need regulations and the availability and use of revascularization services

    Page :767-775

    Vivian Ho, Joseph S. Ross, Brahmajee K. Nallamothu, Harlan M. Krumholz

    Résumé Résumé Plan Plan  
  • ·Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: Does the beneficial effect persist?

    Page :776-782

    Rosa Laura E. van Loon, Elke S. Hoendermis, Marielle G.J. Duffels, Anton Vonk-Noordegraaf, Barbara J.M. Mulder, Hans L. Hillege, Rolf M.F. Berger

    Résumé Résumé Plan Plan  
  • ·Accurate quantification of pulmonary artery diameter in patients with cyanotic congenital heart disease using multidetector-row computed tomography

    Page :783-788

    Yasunobu Hayabuchi, Kazuhiro Mori, Tetsuya Kitagawa, Miki Inoue, Shoji Kagami

    Résumé Résumé Plan Plan  
  • ·Evaluation of cardiac function of the fetus by inferior vena cava diameter pulse waveform

    Page :789-794

    Akira Mori, Noa Uchida, Yoko Ishiguro, Togo Atsuko, Mitsuzuka Kanako, Mikami Mikio

    Résumé Résumé Plan Plan  
  • ·Covered stents in patients with complex aortic coarctations

    Page :795-800

    Gianfranco Butera, Luciane Piazza, Massimo Chessa, Diana Gabriella Negura, Luca Rosti, Raul Abella, Angelica Delogu, Claudia Condoluci, Andrea Magherini, Mario Carminati

    Résumé Résumé Plan Plan